ClinicalTrials.Veeva

Menu

Effect of Probiotic's Consumption on Several Markers in Perforated Appendix Patients with Diffuse Peritonitis

U

Universitas Padjadjaran

Status and phase

Not yet enrolling
Early Phase 1

Conditions

Appendicitis with Perforation
Probiotic
Appendectomy

Treatments

Other: Placebo Group
Dietary Supplement: Lactobacillus plantarum sp Probiotic

Study type

Interventional

Funder types

Other

Identifiers

NCT06856434
SURG-202407.01

Details and patient eligibility

About

Does the administration of the probiotic Lactobacillus plantarum sp. have an impact on reducing leukocyte levels, segmented neutrophil counts, postoperative pain, and length of hospitalization in patients with diffuse peritonitis caused by perforated acute appendicitis who underwent laparotomy appendectomy at Dr. Hasan Sadikin Hospital?

Full description

To determine whether the administration of the probiotic Lactobacillus plantarum sp. to patients with diffuse peritonitis caused by appendiceal perforation undergoing laparotomy appendectomy at Hasan Sadikin Hospital Bandung and Siloam Karawaci Hospital has a significant effect on leukocyte levels, segmented neutrophil counts, postoperative pain levels, and length of hospitalization compared to the placebo group.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed with diffuse peritonitis caused by appendicitis
  • Patients undergoing laparotomic appendectomy.
  • Patients aged 18 years or older.

Exclusion criteria

  • Patients with a history of previous laparotomy.
  • Patients who underwent laparotomy combined with surgery on other parts of the body.
  • Patients with a history of cancer.
  • Patients with pre-existing comorbidities (uncontrolled diabetes mellitus, congestive heart failure, end-stage renal disease [ESRD], human immunodeficiency virus [HIV], and systemic lupus erythematosus [SLE]).
  • Patients with multiple organ dysfunction syndrome (MODS).
  • Patients with prior consumption of probiotics.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

50 participants in 2 patient groups, including a placebo group

Probiotic Group
Experimental group
Description:
Patient with perforated appendicitis who received an intervention
Treatment:
Dietary Supplement: Lactobacillus plantarum sp Probiotic
Placebo Group
Placebo Comparator group
Description:
Patients with perforated appendicitis who did not receive an intervention
Treatment:
Other: Placebo Group

Trial contacts and locations

0

Loading...

Central trial contact

Ricarhdo Valentino Hanafi, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems